These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35955727)

  • 1. A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers.
    Matuszczak M; Kiljańczyk A; Salagierski M
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis.
    Laukhtina E; Shim SR; Mori K; D'Andrea D; Soria F; Rajwa P; Mostafaei H; Compérat E; Cimadamore A; Moschini M; Teoh JY; Enikeev D; Xylinas E; Lotan Y; Palou J; Gontero P; Babjuk M; Witjes JA; Kamat AM; Roupret M; Shariat SF; Pradere B;
    Eur Urol Oncol; 2021 Dec; 4(6):927-942. PubMed ID: 34753702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in bladder cancer: State of the art and future perspectives.
    Crocetto F; Barone B; Ferro M; Busetto GM; La Civita E; Buonerba C; Di Lorenzo G; Terracciano D; Schalken JA
    Crit Rev Oncol Hematol; 2022 Feb; 170():103577. PubMed ID: 34999017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can urinary biomarkers replace cystoscopy?
    Maas M; Bedke J; Stenzl A; Todenhöfer T
    World J Urol; 2019 Sep; 37(9):1741-1749. PubMed ID: 30283995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.
    Lodewijk I; Dueñas M; Rubio C; Munera-Maravilla E; Segovia C; Bernardini A; Teijeira A; Paramio JM; Suárez-Cabrera C
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients choose certainty over burden in bladder cancer surveillance.
    van Osch FHM; Nekeman D; Aaronson NK; Billingham LJ; James ND; Cheng KK; Bryan RT; Zeegers MP
    World J Urol; 2019 Dec; 37(12):2747-2753. PubMed ID: 30903352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
    Ng K; Stenzl A; Sharma A; Vasdev N
    Urol Oncol; 2021 Jan; 39(1):41-51. PubMed ID: 32919875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary markers for bladder cancer diagnosis: A review of current status and future challenges.
    Tomiyama E; Fujita K; Hashimoto M; Uemura H; Nonomura N
    Int J Urol; 2024 Mar; 31(3):208-219. PubMed ID: 37968825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert
    Cowan B; Klein E; Jansz K; Westenfelder K; Bradford T; Peterson C; Scherr D; Karsh LI; Egerdie B; Witjes A; Trainer A; Harris R; Goldfarb B; Flax S; Kroeger R; Boyd B; Liao J; Patel S; Bridge J; Reuter V; Quigley N; Brown S; Zhao S; Satya M; Bates M; Simon IM; Campbell S; Lotan Y
    BJU Int; 2021 Dec; 128(6):713-721. PubMed ID: 33793062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder cancer biomarkers].
    Dobrowolska-Glazar B; Glazar W; Dobrowolski Z; Lipczyński W
    Przegl Lek; 2010; 67(7):479-83. PubMed ID: 21387760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts of tumor markers in bladder cancer.
    Droller MJ
    Urol Clin North Am; 2002 Feb; 29(1):229-34. PubMed ID: 12109349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
    Tan WS; Feber A; Dong L; Sarpong R; Rezaee S; Rodney S; Khetrapal P; de Winter P; Ocampo F; Jalil R; Williams NR; Brew-Graves C; Kelly JD
    BMC Cancer; 2017 Nov; 17(1):767. PubMed ID: 29141603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.
    Karaoglu I; van der Heijden AG; Witjes JA
    World J Urol; 2014 Jun; 32(3):651-9. PubMed ID: 24166285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
    Piao XM; Cha EJ; Yun SJ; Kim WJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
    Beukers W; van der Keur KA; Kandimalla R; Vergouwe Y; Steyerberg EW; Boormans JL; Jensen JB; Lorente JA; Real FX; Segersten U; Orntoft TF; Malats N; Malmström PU; Dyrskjot L; Zwarthoff EC
    J Urol; 2017 Jun; 197(6):1410-1418. PubMed ID: 28049011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
    Brems-Eskildsen AS; Zieger K; Toldbod H; Holcomb C; Higuchi R; Mansilla F; Munksgaard PP; Borre M; Ørntoft TF; Dyrskjøt L
    BMC Cancer; 2010 Nov; 10():646. PubMed ID: 21106093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Pichler R; Tulchiner G; Fritz J; Schaefer G; Horninger W; Heidegger I
    Int J Med Sci; 2017; 14(9):811-819. PubMed ID: 28824318
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial.
    Cochetti G; Rossi de Vermandois JA; Maulà V; Cari L; Cagnani R; Suvieri C; Balducci PM; Paladini A; Del Zingaro M; Nocentini G; Mearini E
    Urol Oncol; 2022 Mar; 40(3):105.e11-105.e18. PubMed ID: 34911649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.